Advanced classical Hodgkin lymphoma
Clinical trials for Advanced classical Hodgkin lymphoma explained in plain language.
Never miss a new study
Get alerted when new Advanced classical Hodgkin lymphoma trials appear
Sign up with your email to follow new studies for Advanced classical Hodgkin lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug pair tame hodgkin lymphoma in older patients?
Disease control CompletedThis trial tests whether combining two drugs, brentuximab vedotin (Adcetris) and bendamustine (Levact), can safely and effectively treat Hodgkin lymphoma in people aged 60 to 80 who have not had prior treatment. The standard therapy, ABVD, often causes lung damage in older adults…
Matched conditions: ADVANCED CLASSICAL HODGKIN LYMPHOMA
Phase 1/2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug combo shows promise in advanced hodgkin lymphoma trial
Disease control CompletedThis large phase 3 trial tested a new drug combination (brentuximab vedotin plus AVD) against the standard ABVD regimen in 1,334 patients with advanced Hodgkin lymphoma. The goal was to see if the new combo could delay cancer progression better. Results showed improved progressio…
Matched conditions: ADVANCED CLASSICAL HODGKIN LYMPHOMA
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug combo shows promise against hodgkin lymphoma
Disease control CompletedThis study compared two chemotherapy regimens for people with advanced classical Hodgkin lymphoma. One group received the standard ABVD regimen, while the other received a newer combination called BV+AVD, which includes the targeted drug brentuximab vedotin. The trial enrolled 60…
Matched conditions: ADVANCED CLASSICAL HODGKIN LYMPHOMA
Sponsor: Helwan University • Aim: Disease control
Last updated Jun 26, 2026 17:09 UTC